EUVIMEDObjevte EUVIMED
Editorial

Sperm DNA integrity: a special issue exploring the causes, consequences, and treatment of DNA damage in human spermatozoa

Robert John Aitken iD

Andrology · 2023-11 · 11 (8) · 1541-1544

DOI: 10.1111/andr.13503 ↗

At a glance

Editorial in Andrology, published online on 2023-10-19. Written by Robert John Aitken. Institution: Priority Research Centre for Reproductive Science, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW, Australi…. Major MEDLINE topics: Semen, Spermatozoa. Cited 12 times so far (Crossref); 32 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Since the pioneering studies by Don Evenson and colleagues first opened our eyes to the existence of DNA damage in subpopulations of human spermatozoa,1 important questions have been raised concerning the causes, clinical significance, and resolution of this phenomenon.2 In this Special Issue of Andrology, we have brought together a collection of cutting-edge research articles and reviews, reflecting the most recent advances in this area. We hope that this collection of articles will help andrologists recognize the importance of DNA damage in spermatozoa, understand where the knowledge gaps are, and thoughtfully engage in research designed to enhance our capacity to diagnose and manage this critical element of semen quality. In terms of the etiology of DNA damage, there appears to be a general consensus that oxidative stress makes a major contribution to its induction.2 As highlighted in this Special Issue, we are beginning to gather a detailed understanding as to why oxidative stress is so important in the causation of sperm DNA damage, as well as the key role that enzymes such as topoisomerase might play in this process.2 However, the source of the oxidative stress driving this DNA damage has remained largely unresolved. A complication in this regard is that every semen sample is contaminated with leukocytes, particularly neutrophils, and these cells are many times more active in generating reactive oxygen species (ROS) than spermatozoa. So, when high levels of ROS generation are observed in human semen, it is difficult to determine whether the source of this activity is the spermatozoa themselves or simply the presence of contaminating leukocytes. Correlative studies have previously indicated the importance of leukocyte contamination in determining the overall level of ROS generation in unfractionated ejaculates.3 However, when spermatozoa were isolated by discontinuous gradient density centrifugation (DGC), then sperm populations could be identified that were also actively generating ROS.3, 4 In this Special Issue, Hajnal et al.5 have made a critical contribution to this debate by developing flow cytometry protocols that permit the discrimination of ROS generation by leukocytes and spermatozoa. They conclude that while both cell types are capable of generating ROS, there is also a critical interaction between these cell types such that leukocyte contamination enhances ROS generation by spermatozoa. This phenomenon has been described before6.7 and may reflect the ability of lipid aldehydes generated in spermatozoa as a result of leukocyte-induced oxidative stress, to bind to proteins in the sperm mitochondrial electron transport chain and stimulate increased ROS production in a self-reinforcing cycle.8 If oxidative stress is such a critical factor in the etiology of sperm DNA damage, then surely antioxidants should have some therapeutic benefit in this situation. In order to test this hypothesis, it is important that methods are developed for screening patients for evidence that oxidative stress actually exists. If antioxidants are given to patients who are not compromised in this manner, the result may be the inadvertent induction of reductive stress, which can be just as harmful as its oxidative counterpart.9 Diagnostic methods such as the MiOXSYS® and OxiSperm® II have been developed commercially, however neither of these assays appears to provide any meaningful assessment of oxidative stress in spermatozoa, as revealed by Castleton et al. and others.10-13 Moreover, Kuroda et al.14 observed no significant correlation between sperm DNA damage and oxidative stress as measured by the MiOXSYS® system, despite the abundance of data revealing the fundamental importance of free radical attack in the induction of sperm DNA fragmentation.15 Clearly, improved methods are needed to detect oxidative stress in patients presenting with high levels of sperm DNA damage. We cannot proceed with much-needed clinical trials, designed to assess the potential therapeutic application of antioxidants in this context, until such methods become available. If we cannot yet treat the oxidative stress at source perhaps, in the interim, we can develop methods for the physical selection of spermatozoa exhibiting minimal levels of oxidative stress and DNA damage for use in assisted conception procedures. In this Special Issue, Villeneuve et al.16 describe a novel electrophoretic sperm isolation procedure that achieves this end. In comparison with conventional DGC procedures, this device isolated spermatozoa with significantly improved motility, reduced DNA fragmentation, and dramatically lower levels of oxidative DNA damage; moreover, these outcomes were achieved in a fraction of the time (∼6 min) taken by DGC (typically ∼55 min).17 Similarly, Kocur et al.18 demonstrated that a microfluidic system for sperm isolation not only surpassed DGC methodology for the isolation of spermatozoa expressing low levels of total and double-stranded DNA fragmentation, but also improved embryo euploidy rates and, critically, live birth rates. One potential limitation of such microfluidic systems is that they are entirely dependent on the intrinsic motility of the spermatozoa, necessitating the exclusion of severely oligoasthenozoospermic males from the study.18 Quite how such microfluidic and electrophoretic systems will compare across the full range of semen quality observed in infertility clinics, will be an important question to address in future studies. As an alternative to the isolation of high-quality sperm subpopulations using technologies such as microfluidics or electrophoresis, it may also be possible to surgically retrieve spermatozoa from regions of the reproductive tract where oxidative DNA damage is minimal. Specifically, Esteves et al.19 present an elegant exploration of the concept that the surgical recovery of testicular spermatozoa might lower levels of sperm DNA damage in ICSI cycles, because these cells have not yet experienced the stressful oxidative environments created either by the epididymis or following ejaculation. The evidence supporting the use of testicular spermatozoa for procedures such as ICSI looks compelling although, as the authors point out, the data are still limited and, as yet, we have no definitive answer as to the impact of such treatment strategies on the health and well-being of the offspring. In addition to the development of novel procedures for sperm isolation and recovery, we might also explore measures to better manage sperm DNA damage, in cases where the etiology is known. For example, if oxidative stress is centrally involved in the etiology of sperm DNA damage, we might ask what factors are involved in creating such stress to the point that both the genetic and epigenetic integrity of the spermatozoa are significantly compromised. One of many potential causes of oxidative stress with the male reproductive system is the global pandemic in obesity. In this Special Issue, Peel et al.20 summarized the latest animal and human data suggesting that obesity is associated with an increase in sperm DNA damage via a range of direct and indirect mechanisms. These authors highlight the potential role of oxidative stress in not only mediating the impact of obesity on sperm DNA damage, but also in the transgenerational inheritance of obesity. In this context, they raise the intriguing possibility that such inheritance might involve an epigenetic change mediated by oxidative damage to the small RNA species harboured by the fertilizing spermatozoon. In addition to obesity, sperm DNA damage may occasionally be induced iatrogenically. Testicular germ cell tumors are the most common form of neoplasia in young men of reproductive age. Fortunately, this form of cancer is very readily treated with a 5-year survival rate of 95%.21 However, a critical legacy of this treatment is the expression of high levels of sperm DNA damage that may persist for as long as 3 years in around 5% of patients according to Farnetani et al.21 We cannot prevent such DNA damage from occurring, it is an unavoidable consequence of chemotherapy; however, in light of the new information provided by Farnetani et al.21 we can give patients informed advice as to when the reproductive risks associated with such treatment might have subsided to acceptable levels. Other drugs that are in common therapeutic usage can also induce DNA damage in spermatozoa. For example, the paper by da Costa Nunes Gomes et al.22 highlights the ability of methylphenidate hydrochloride, a pharmaceutical agent commonly used in the treatment of attention-deficit hyperactive disorder, to cause high levels of sperm DNA damage. Smoking, exposure to non-ionizing electromagnetic radiation, age, the warm environmental conditions associated with summer and the presence of comorbidities such as leukocytospermia, diabetes, epilepsy (or, more likely, the drugs used to treat epilepsy), infection (including COVID 19), exposure to environmental toxicants, and cryopreservation are all significantly associated with high levels of DNA damage in the male germ line.2, 23 Continuing research into the extensive array of environmental, lifestyle, and clinical factors associated with DNA damage in spermatozoa will be extremely helpful, if we are to develop meaningful measures to manage this pathology in a clinical context. Whatever the cause of the DNA damage, there is a growing volume of data to indicate that it has clinical significance—not so much for the process of conception itself but for the viability, health, and wellbeing of the offspring.2 Thus, this Special Issue includes an excellent study by Busnelli et al.24 which emphasizes the clear association that exists between sperm DNA damage and idiopathic recurrent early pregnancy loss. A causative impact of sperm DNA damage on embryonic development is implied in such studies24 and has been clearly confirmed in animals25 including a paper published in this Special Issue by da Costa Nunes Gomes et al.22 However, large-scale prospective studies are now called for, to confirm this relationship in a human context and open up the possibility of intervention trials.24 In considering the clinical impact of sperm DNA damage, the male gamete cannot be considered in isolation, because the clinical consequences of such damage may also depend on the ability of the oocyte to detect and repair genetic/epigenetic defects in the fertilizing spermatozoon.26-29 The involvement of both male and female gametes in determining the consequences of sperm DNA damage for the embryo has been captured by the 'post-meiotic oocyte collusion hypothesis',28 which sets out to explain how DNA damage in spermatozoa can ultimately translate into an increased mutational load in the progeny. Assessing the ability of the oocyte to cope with sperm DNA damage would be very valuable in a clinical context, where ICSI is being used to treat male infertility. In this context, the paper by Braga et al.29 supports the use of simple morphological markers (such as cytoplasmic granulation, vacuolation, or dark cytoplasm) to determine oocyte quality and thereby predict the likely risk of pathological consequences following insemination with DNA damaged spermatozoa. As this Special Issue reveals, we have made significant progress in our understanding of the causes and clinical significance of sperm DNA damage in recent years. However, we still have some way to travel. The development of novel consensus methods for detecting DNA damage,14 determining which patients should be assessed,30 elucidation of the relative importance of single and double strand breaks,31 the significance of oxidative stress in the induction of such damage,26 the potential therapeutic role for antioxidants,32 and the consequences of sperm DNA damage in terms of male fertility and the health and wellbeing of the offspring,23, 24, 26 all need to be elucidated before the true clinical significance of such damage becomes clear. RJA is Scientific Director of Memphasys Ltd, a Sydney-based biotechnology company specializing in the design of reagents and devices for the assisted conception industry.

Subjects

MeSH terms (MEDLINE)

SemenSpermatozoaHumansMaleDNADNA DamageOxidative Stress

Author keywords

DNA damageclinicaletiologymanagementoxidative stressspermatozoa

Substances

DNA

Authors and institutions

  • Priority Research Centre for Reproductive Science, College of Engineering, Science and Environment, University of Newcastle, Callaghan, NSW, Australia.
  • Hunter Medical Research Institute (HMRI), New Lambton, NSW, Australia.

ORCID profiles: Robert John Aitken

Cite

APA

Aitken, R. J. (2023). Sperm DNA integrity: a special issue exploring the causes, consequences, and treatment of DNA damage in human spermatozoa. Andrology, 11(8), 1541-1544. https://doi.org/10.1111/andr.13503

Vancouver

Aitken RJ. Sperm DNA integrity: a special issue exploring the causes, consequences, and treatment of DNA damage in human spermatozoa. Andrology. 2023;11(8):1541-1544. doi:10.1111/andr.13503

BibTeX
@article{Aitken2023,
  author = {Aitken, Robert John},
  title = {Sperm DNA integrity: a special issue exploring the causes, consequences, and treatment of DNA damage in human spermatozoa},
  journal = {Andrology},
  year = {2023},
  volume = {11},
  number = {8},
  pages = {1541--1544},
  doi = {10.1111/andr.13503}
}
Start for free →